Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18286034 | 0.88 | ALOX15 (0.32) | ALOX15 | |
| SCHEMBL20393963 | 0.86 | LMNA (0.39) | ALOX15TSHRTDP1LMNAHSD17B10 | |
| SCHEMBL1274252 | 0.81 | ALOX15 (0.38) | ALOX15LMNAHSD17B10 | |
| SCHEMBL8935690 | 0.76 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1 | |
| SCHEMBL22406298 | 0.75 | SMN1; SMN2 (0.44) | ALDH1A1TSHRLMNA | |
| SCHEMBL29048958 | 0.74 | TDP1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL27818206 | 0.74 | ALOX15 (0.36) | ALOX15ALDH1A1TSHRTDP1LMNA | |
| SCHEMBL27583662 | 0.74 | DGAT1 (0.36) | ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL1764325 | 0.73 | MGAM (0.37) | ALOX15 | |
| SCHEMBL17652003 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10781166-B2 | Biocompositions for 3D printing | 3D-BIOMATERIALS, LLC (US) | 2020-09-22 | — | — | US | disclosed |
| US-20190194123-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | 3D - BIOMATERIALS, LLC | 2019-06-27 | — | — | US | disclosed |
| WO-2019067599-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | NOVOSET, LLC (US) | 2019-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194123-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | HTR3D, ILK, ITGB3 | ALOX15 1271/4885ALDH1A1 1925/4885TSHR 4733/4885 |
| US-10781166-B2 | Biocompositions for 3D printing | HTR3D, ILK, ITGB3 | ALOX15 1271/4885ALDH1A1 1925/4885TSHR 4733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.